长新冠与不良妊娠结局的多中心前瞻性队列研究
本研究基于RECOVER-Adult多中心前瞻性纵向队列,纳入2021年10月至2024年1月期间有SARS-CoV-2感染史且孕前或孕期完成症状调查的603名参与者,评估长新冠分类与不良妊娠结局的关联。主要结局为37周前早产,采用倾向性评分全匹配估计平均处理效应。结果显示可能长新冠与早产无显著关联,但在处理组平均处理效应敏感性分析中与妊娠期高血压疾病风险升高相关。
要点
- 可能长新冠与37周前早产无显著关联(调整后发生率8.1% vs 9.6%,ARR 0.82,95%CI 0.36-1.90)。
- 处理组平均处理效应分析中,可能长新冠与妊娠期高血压疾病风险升高相关(39.0% vs 25.9%,ARR 1.51,95%CI 1.12-2.03)。
- 可能长新冠组更常见困难支付账单、食物不安全、因费用错过医疗和医疗歧视等不良健康社会决定因素。
核心结论
- 可能长新冠分类与早产或若干其他不良妊娠结局无显著关联,但与妊娠期高血压疾病的关联需进一步研究。
研究设计与样本
- RECOVER-Adult为多中心前瞻性纵向队列研究,纳入2021年10月至2024年1月入组的有或无SARS-CoV-2感染史的成人。
- 本分析纳入有SARS-CoV-2感染且孕前或孕期至少完成一次症状调查以分类长新冠状态的603名参与者。
- 参与者按长新冠研究指数(LCRI)分为可能长新冠(评分≥11)或长新冠不确定(评分0-10),采用倾向性评分全匹配估计平均处理效应。
主要发现
- 603名参与者中118名(19.6%)在孕前或孕期被分类为可能长新冠。
- 可能长新冠组更常见困难支付费用和账单、食物不安全、因费用错过医疗及医疗歧视,且孕前BMI更高。
- 主要平均处理效应分析中,可能长新冠与早产无关联(调整后发生率8.1% vs 9.6%,ARR 0.82,95%CI 0.36-1.90),与次要结局也无关联。
- 处理组平均处理效应敏感性分析中,可能长新冠与早产仍无关联(ARR 1.11,95%CI 0.60-2.06),但与妊娠期高血压疾病风险升高相关(调整后发生率39.0% vs 25.9%,ARR 1.51,95%CI 1.12-2.03)。
临床怎么用
- 对于有SARS-CoV-2感染史且符合可能长新冠分类的孕妇,应关注妊娠期高血压疾病的发生风险。
- 可能长新冠孕妇常合并不良健康社会决定因素,临床评估时需综合考虑社会支持与医疗可及性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate whether there is an association between a maternal classification of Long COVID and adverse pregnancy outcomes. METHODS: RECOVER (Researching COVID to Enhance Recovery)-Adult is a multicenter prospective longitudinal cohort study of adults with and without prior severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection enrolled from October 2021 to January 2024. This analysis included participants with a SARS-CoV-2 infection and at least one symptom survey for classification of Long COVID status recorded before or during pregnancy. Participants were classified as either likely having Long COVID (LCRI [Long COVID Research Index] score of 11 or higher) or as having Long COVID-indeterminate (LCRI score 0-10), with comparisons made between groups. The primary outcome was preterm birth before 37 weeks of gestation. Secondary outcomes included hypertensive disorders of pregnancy, cesarean delivery, neonatal intensive care admission, and small-for-gestational-age birth weight (below the 10th percentile). Propensity score methods with full matching were used to balance differences in baseline characteristics in estimating an average treatment effect, with a sensitivity analysis estimating the average treatment effect among the treated. RESULTS: Among 603 participants, 118 (19.6%) were classified as likely having Long COVID before or during pregnancy. Participants classified as likely having Long COVID were more likely to have specific adverse social determinants of health (difficulty covering expenses and paying bills, food insecurity, missed care because of cost, medical discrimination) and had higher prepregnancy body mass index (BMI) than those who were classified as having Long COVID-indeterminate. In the primary average treatment effect analysis, there was no association between likely Long COVID and preterm delivery (adjusted outcome rate 8.1% exposed vs 9.6% unexposed, absolute risk reduction [ARR] 0.82, 95% CI, 0.36-1.90) or secondary outcomes. In average treatment effect among the treated sensitivity analyses, likely Long COVID was similarly not associated with preterm delivery (ARR 1.11, 95% CI, 0.60-2.06) but was associated with an increased risk of hypertensive disorders of pregnancy (adjusted outcome rate 39.0% exposed vs 25.9% unexposed, ARR 1.51, 95% CI, 1.12-2.03) but not with other secondary outcomes. CONCLUSION: A classification of likely Long COVID was not significantly associated with preterm birth or several other adverse pregnancy outcomes. However, the association with hypertensive disorders of pregnancy in the average treatment effect among the treated analysis highlights the need for further research.
引用
- Metz TD, Sandoval GJ, Allshouse AA, et al. Pregnancy Outcomes in Individuals With Long COVID. Obstet Gynecol. 2026. PMID: 42659593. doi:10.1097/AOG.0000000000006410
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。